Adalimumab in Ankylosing Spondylitis: An Evidence-Based Review of Its Place in Therapy

Core Evidence - New Zealand
doi 10.2147/ce.s7432
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Transarterial Chemoembolization for Hepatocellular Carcinoma: An Evidence-Based Review of Its Place in Therapy

Journal of Hepatocellular Carcinoma
2015English

Rasburicase in the Management of Tumor Lysis: An Evidence-Based Review of Its Place in Therapy

Core Evidence
MedicineReviewsReferencesPharmacology
2015English

Symptomatic Therapy for Ankylosing Spondylitis

Modern Rheumatology Journal
2012English

Pioglitazone and Metformin Fixed-Dose Combination in Type 2 Diabetes Mellitus: An Evidence-Based Review of Its Place in Therapy

Core Evidence
MedicineReviewsReferencesPharmacology
2007English

Leukocytoclastic Vasculitis Associated With Adalimumab Treatmentin a Patient With Ankylosing Spondylitis

Nauchno-Prakticheskaya Revmatologiya
RheumatologyAllergyImmunology
2010English

Correction To: Secukinumab: A Review in Ankylosing Spondylitis

Drugs
Pharmacology
2019English

Sulphasalazine in Ankylosing Spondylitis.

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1986English

Effectiveness and Safety of Adalimumab in Patients With Ankylosing Spondylitis or Psoriatic Arthritis and History of Anti-Tumor Necrosis Factor Therapy

Arthritis Research and Therapy
RheumatologyAllergyImmunology
2010English

Anti-TNF Therapy in Ankylosing Spondylitis: Insights for the Clinician

Therapeutic Advances in Musculoskeletal Disease
RheumatologyOrthopedicsSports Medicine
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy